BioCentury | Nov 7, 2011
Company News

Marinomed management update

...Vienna, Austria Business: Infectious, Inflammation Hired: Angelika Bodenteich as head of development, formerly CMO of onepharm Research & Development GmbH WIR...
BioCentury | Jul 11, 2011
Emerging Company Profile

Savira: Capping influenza

...glycyrrhizin derivatives from onepharm Research & Development GmbH , which spun out its influenza assets into Savira in 2009. onepharm...
...Institutions Mentioned European Molecular Biology Laboratory (EMBL), Heidelberg, Germany Fujifilm Holdings Corp. (Tokyo:4901), Tokyo, Japan onepharm Research & Development GmbH...
...Disease focus: Infectious Clinical status: Preclinical Founded: 2009 by European Molecular Biology Laboratory (EMBL) and onepharm Research & Development GmbH...
BioCentury | Mar 23, 2009
Company News

onepharm, Wuhan Huana Biological Engineering Co. Ltd. deal

...Wuhan has completed preclinical testing of the small molecule against an undisclosed target for IBD. onepharm...
...start Phase I testing in 1H10. Wuhan is eligible for undisclosed milestones and single-digit royalties. onepharm Research & Development GmbH...
BioCentury | Jun 2, 2008
Company News

Bionetworks GmbH, onepharm deal

...I trial by year end. Financial terms were not disclosed. Bionetworks GmbH , Munich, Germany onepharm Research & Development GmbH...
BioCentury | Nov 5, 2007
Company News

Minophagen, onepharm deal

...to develop and market Minophagen's OPM-3001 in Europe and the U.S. to treat influenza infection. onepharm...
...eligible for royalties and will retain rights to market OPM-3001 for influenza in Asia, where onepharm...
...root, to treat chronic HCV infection in Asia. Minophagen Pharmaceutical Co. Ltd. , Tokyo, Japan onepharm Research & Development GmbH...
BioCentury | Jul 23, 2007
Company News

onepharm Research and Development GmbH management update

onepharm Research and Development GmbH , Vienna, Austria Business: Infectious Promoted: Oliver Szolar to CSO, formerly head of analytical operations WIR Staff Infectious...
BioCentury | Nov 14, 2005
Company News

onepharm Research and Development GmbH management update

onepharm Research and Development GmbH , Vienna, Austria Business: Infectious Hired: Otto Doblhoff as COO, while remaining a professor of bioprocessing and biosafety at the University of Applied Life Sciences WIR Staff Infectious...
Items per page:
1 - 7 of 7
BioCentury | Nov 7, 2011
Company News

Marinomed management update

...Vienna, Austria Business: Infectious, Inflammation Hired: Angelika Bodenteich as head of development, formerly CMO of onepharm Research & Development GmbH WIR...
BioCentury | Jul 11, 2011
Emerging Company Profile

Savira: Capping influenza

...glycyrrhizin derivatives from onepharm Research & Development GmbH , which spun out its influenza assets into Savira in 2009. onepharm...
...Institutions Mentioned European Molecular Biology Laboratory (EMBL), Heidelberg, Germany Fujifilm Holdings Corp. (Tokyo:4901), Tokyo, Japan onepharm Research & Development GmbH...
...Disease focus: Infectious Clinical status: Preclinical Founded: 2009 by European Molecular Biology Laboratory (EMBL) and onepharm Research & Development GmbH...
BioCentury | Mar 23, 2009
Company News

onepharm, Wuhan Huana Biological Engineering Co. Ltd. deal

...Wuhan has completed preclinical testing of the small molecule against an undisclosed target for IBD. onepharm...
...start Phase I testing in 1H10. Wuhan is eligible for undisclosed milestones and single-digit royalties. onepharm Research & Development GmbH...
BioCentury | Jun 2, 2008
Company News

Bionetworks GmbH, onepharm deal

...I trial by year end. Financial terms were not disclosed. Bionetworks GmbH , Munich, Germany onepharm Research & Development GmbH...
BioCentury | Nov 5, 2007
Company News

Minophagen, onepharm deal

...to develop and market Minophagen's OPM-3001 in Europe and the U.S. to treat influenza infection. onepharm...
...eligible for royalties and will retain rights to market OPM-3001 for influenza in Asia, where onepharm...
...root, to treat chronic HCV infection in Asia. Minophagen Pharmaceutical Co. Ltd. , Tokyo, Japan onepharm Research & Development GmbH...
BioCentury | Jul 23, 2007
Company News

onepharm Research and Development GmbH management update

onepharm Research and Development GmbH , Vienna, Austria Business: Infectious Promoted: Oliver Szolar to CSO, formerly head of analytical operations WIR Staff Infectious...
BioCentury | Nov 14, 2005
Company News

onepharm Research and Development GmbH management update

onepharm Research and Development GmbH , Vienna, Austria Business: Infectious Hired: Otto Doblhoff as COO, while remaining a professor of bioprocessing and biosafety at the University of Applied Life Sciences WIR Staff Infectious...
Items per page:
1 - 7 of 7